Mazdutide
A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
Innovent · Phase 2 · Active, not recruiting · Enrollment 141
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| IBI362 4.0mg | n/r | n/r | n/r | n/r | n/r |
| placebo | n/r | n/r | n/r | n/r | n/r |
| IBI362 6.0mg | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.